Yen Thi Hai Nguyen

Yen Thi Hai Nguyen


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2022 in Healthcare
Verified
Journal Article
Open access
PDF file
LLLoan Thi Thuy Le
Loan Thi Thuy Le
TNTuan Anh Nguyen
Tuan Anh Nguyen
NNNghia An Nguyen
Nghia An Nguyen
YNYen Thi Hai Nguyen
Yen Thi Hai Nguyen
BNBe Hai Nguyen
Be Hai Nguyen
Thang NguyenThang Nguyen
Thang Nguyen
Background: Helicobacter pylori (H. pylori) infection causes gastritis, duodenal and gastric ulcers, and gastric cancer. H. pylori eradication efficacy is low worldwide, and antibiotic resistance is the leading cause of therapy failure; therefore, this study was performed to determine the characteristics of antibiotic resistance of H. pylori in children with gastritis, duodenal and gastric ulcer. Methods: A cross-sectional study was conducted on 237 pediatric patients diagnosed with gastroduodenal inflammation and ulcer at two hospitals in Vietnam from March 2019 to April 2022. Pediatric patients with positive H. pylori tests continued to do E-tests to measure the minimum inhibitory concentration of the antibiotic so that we could prescribe effective antibiotics based on the sensitivity. Results: In 237 pediatric patients (51.1% males) with a median age of 10.3 years (range 5–16 years), endoscopic images showed that inflammatory lesions and peptic ulcers accounted for 69.2% and 30.8%, respectively. Resistance rates of H. pylori were 80.6% to clarithromycin (CLR), 71.7% to amoxicillin (AMX), 49.4% to metronidazole (MTZ), 45.1% to levofloxacin (LEV), and 11.4% to tetracycline (TET); dual resistance to AMX + CLR was 64.2%, AMX + LEV 35%, AMX + MTZ 33.3%, CLR + MTZ 32.5%, and TET + MTZ 7.2%. The frequency of clarithromycin resistance was significantly increased, particularly in pediatric patients who had received prior H. pylori treatment. The percentage of amoxicillin resistance increased with age; amoxicillin resistance of H. pylori was more prevalent among pediatric patients with peptic ulcers than those with gastroduodenal inflammation and higher in males than females. Conclusions: The proportions of resistance to CLR, AMX, MTZ, and LEV were extremely high, in contrast to TET, which was lower in pediatric patients. Our study suggests that the standard triple therapy with CLR should be limited as the empiric therapy for pediatric patients, and we should consider using eradication regimens with TET for children over 8 years of age if the medical facility is not qualified to perform antibiotic susceptibility tests of H. pylori in the Mekong Delta.

8 July 2022 in Children
Verified
Journal Article
Open access
PDF file
LLLoan T. T. Le
Loan T. T. Le
TNTuan A. Nguyen
Tuan A. Nguyen
NNNghia A. Nguyen
Nghia A. Nguyen
YNYen Thi Hai Nguyen
Yen Thi Hai Nguyen
BNBe Hai Nguyen
Be Hai Nguyen
Thang NguyenThang Nguyen
Thang Nguyen
Background: The efficacy of Helicobacter pylori (H. pylori) eradication therapy for children is currently low, and antibiotic resistance is a significant cause of treatment failure. The purpose of this study was to evaluate the H. pylori eradication efficacy of therapy based on antimicrobial susceptibility in pediatric patients with gastritis and peptic ulcer. Methods: This study was conducted at Can Tho Children’s Hospital and Can Tho University of Medicine and Pharmacy Hospital between March 2019 and April 2022. We performed an upper gastrointestinal endoscopy, cultured H. pylori from biopsies of gastric mucosa, determined antibiotic sensitivities to H. pylori by the E-test method, and treated eradication based on the antibiotic susceptibilities of bacteria. After at least 4 weeks of eradication therapy, we assessed the effectiveness of treatment with a breath test. Results: Among 237 children recruited in this study, 48.9% were boys and 51.1% were girls, and the mean age was 10.03 ± 2.53 years. We determined that 80.6% of H. pylori were resistant to clarithromycin, as well as amoxicillin, metronidazole, levofloxacin, and tetracycline, at 71.7%, 49.4%, 45.1%, and 11.4%, respectively. The overall eradication rate of H. pylori was 83.1% (172/207). Among therapies tailored to antimicrobial susceptibility, the bismuth quadruple regimen achieved the greatest success, but the efficacy of triple therapy with esomeprazole + AMX + CLR/MTZ was low. Conclusions: Tailored eradication therapy was highly successful in our study but did not achieve over 90%. We recommend that in countries with a high prevalence of antibiotic resistance in H. pylori strains, particularly where the amoxicillin-resistance rate of H. pylori is high, therapy tailored to antimicrobial susceptibility should be used as first-line therapy, and bismuth and tetracycline should be added to enhance the eradication efficacy in children.

12 May 2022 in Tạp chí Y Dược học Cần Thơ
Verified
Journal Article
Closed access
PDF file
YNYen Thi Hai Nguyen
Yen Thi Hai Nguyen
QLQuoc Binh Luong
Quoc Binh Luong
Đặt vấn đề: Tỷ lệ đề kháng kháng sinh của vi khuẩn gây bệnh ngày một gia tăng gây khó khăn cho việc lựa chọn kháng sinh, gây tốn kém về kinh tế cho việc điều trị các bệnh nhiễm khuẩn. Mục tiêu nghiên cứu: 1). Xác định tỷ lệ các chủng vi khuẩn phân lập được từ các mẫu bệnh phẩm; 2). Mô tả sự đề kháng kháng sinh của các chủng vi khuẩn phân lập được. Đối tượng và phương pháp nghiên cứu: 627 chủng vi khuẩn gây nhiễm khuẩn được phân lập, định danh và làm kháng sinh đồ theo phương pháp kháng sinh đồ tự động. Kết quả: Trong số loại chủng vi khuẩn phân lập được, S. aureus chiếm tỷ lệ cao nhất (22,8%), Staphylococcus spp. (17,4%), S. pneumoniae (16,2%), Klebsiella spp. (11,9%) và E. coli (9,7%). S. aureus đề kháng với các kháng sinh erythromycin (71,6%), clindamycin (78,7%), gentamycin (50,3%); vancomycin (10,4%). Staphylococus spp. đề khángvới các kháng sinh erythromycin (67,0%), clindamycin (57,5%), levofloxacin (50,5%). S. pneumoniae đề kháng cao với erythromycin (84,2%). E. coli đề kháng cao với aztreonam (81,7%), piperacillin và levofloxacin (78,7%). Klebsiella spp. đề kháng cao với piperacillin (83,8%). Pseudomonas spp. đề kháng với các kháng sinh ciprofloxacin (38,1%), piperacillin (38,6%) và levofloxacin (40,0%). Kết luận: S. aureus chiếm tỷ lệ cao nhất (22,8%), khả năng đề kháng kháng sinh của các chủng vi khuẩn chiếm tỷ lệ cao.

16 October 2023
Verified
Preprint
Open access
PDF file
LNLong Nguyen Nguyen
Long Nguyen Nguyen
TPThi Hoai Tran Phan
Thi Hoai Tran Phan
YNYen Thi Hai Nguyen
Yen Thi Hai Nguyen
TNThi Be Hai Nguyen
Thi Be Hai Nguyen
The incidence of Pseudomonas aeruginosa causing nosocomial infections has increased in recent years, along with the emergence of resistant strains of bacteria causing mortality. Many recent studies have shown increased resistance to colistin, which is the last resort for treating multidrug-resistant P. aeruginosa . A cross-sectional descriptive study and convenience sample were conducted to determine the percentage of infections, rates of seven antibiotics, and colistin resistance in P. aeruginosa strains isolated in Can Tho Central General Hospital and relevant factors from June 2020 to April 2021. P. aeruginosa infection rate was 7.9%. The specimens contained 233 strains of P. aeruginosa isolated. Incident rates in males/females were 9.3%/6.2%, the most of 19-29 years. The highest rate was in urine specimens (9.8%) and sputum (8.8%). The male sex had a higher infection rate than the female, and urine samples accounted for the highest rate of P. aeruginosa infections (13.9%). The rate of P. aeruginosa infections was associated with gender and various species (p<0.05). The prevalence of P. aeruginosa infections showed an association with gender and types of specimens (p<0.05). The highest resistance rate in P. aeruginosa against ciprofloxacin was 60.5%, next to gentamicin and imipenem (52.4% and 50.2%). 3% P. aeruginosa against colistin. Keywords: Pseudomonas aeruginosa ; drug resistance; Pseudomonas infection; colistin